Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Severe polycystic liver disease as a rare indication for liver transplant.
Pol Arch Intern Med. 2020 Nov 30;130(11):1005-1006. doi: 10.20452/pamw.15576. Epub 2020 Aug 21.
Pol Arch Intern Med. 2020.
PMID: 32820882
Free article.
No abstract available.
Hepatic granulomas as an extraintestinal manifestation of Crohn disease.
Janiak M, Jabłońska A, Skrobot K, Perdyan A, Pieńkowska J, Adrych K.
Janiak M, et al. Among authors: skrobot k.
Pol Arch Intern Med. 2020 Mar 27;130(3):240-241. doi: 10.20452/pamw.15147. Epub 2020 Jan 17.
Pol Arch Intern Med. 2020.
PMID: 31951221
Free article.
No abstract available.
Item in Clipboard
Characteristics of patients with moderate-to-severe ulcerative colitis treated with vedolizumab: results from a Polish multicenter, prospective, observational real-life study (the POLONEZ study).
Cichoż-Lach H, Michalak A, Kopertowska-Majchrzak M, Eder P, Stawczyk-Eder K, Waszak K, Talar-Wojnarowska R, Zatorski H, Solarska-Półchłopek A, Chmielnicki J, Filip R, Pękala A, Janiak M, Skrobot K, Kasińska E, Krogulecki M, Królikowski P, Kłopocka M, Liebert A, Poniewierka E, Smoła I, Gąsiorowska A, Kaczka A, Wypych J, Wojciechowski K, Drygała S, Zagórowicz E.
Cichoż-Lach H, et al. Among authors: skrobot k.
Therap Adv Gastroenterol. 2021 Aug 30;14:17562848211036456. doi: 10.1177/17562848211036456. eCollection 2021.
Therap Adv Gastroenterol. 2021.
PMID: 34484422
Free PMC article.
Item in Clipboard
Real-world effectiveness and safety of vedolizumab induction therapy for ulcerative colitis: A prospective nationwide Polish observational study.
Zagórowicz E, Cichoż-Lach H, Kopertowska-Majchrzak M, Eder P, Stawczyk-Eder K, Talar-Wojnarowska R, Zatorski H, Solarska-Półchłopek A, Filip R, Janiak M, Skrobot K, Kłopocka M, Liebert A, Kaczka A, Wojciechowski K, Drygała S, Michalak A.
Zagórowicz E, et al. Among authors: skrobot k.
Adv Clin Exp Med. 2024 Jan;33(1):69-77. doi: 10.17219/acem/162969.
Adv Clin Exp Med. 2024.
PMID: 37166016
Free article.
Item in Clipboard
Real-world outcomes of 54-week vedolizumab therapy and response durability after treatment discontinuation in ulcerative colitis: results from a multicenter prospective POLONEZ study.
Eder P, Kłopocka M, Cichoż-Lach H, Talar-Wojnarowska R, Kopertowska-Majchrzak M, Michalak A, Filip R, Waszak K, Stawczyk-Eder K, Janiak M, Skrobot K, Liebert A, Zatorski H, Solarska-Półchłopek A, Krogulecki M, Pękała A, Poniewierka E, Smoła I, Kaczka A, Wojciechowski K, Drygała S, Zagórowicz E.
Eder P, et al. Among authors: skrobot k.
Therap Adv Gastroenterol. 2023 Feb 14;16:17562848231151295. doi: 10.1177/17562848231151295. eCollection 2023.
Therap Adv Gastroenterol. 2023.
PMID: 36818601
Free PMC article.
Item in Clipboard
Cite
Cite